WE
ALT icon

Wealth Effects’s Altimmune ALT Stock Holding History

Wealth Effects’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$406K Buy
131,950
+20,200
+18% +$85.8K 0.14% 130
2025
Q4 		$403K Buy
111,750
+51,900
+87% +$226K 0.13% 125
2025
Q3 		$226K Buy
59,850
+28,100
+89% +$108K 0.07% 190
2025
Q2 		$123K Buy
31,750
+900
+3% +$4.87K 0.05% 197
2025
Q1 		$154K Sell
30,850
-2,000
-6% -$12.7K 0.06% 188
2024
Q4 		$237K Sell
32,850
-2,200
-6% -$16.8K 0.08% 184
2024
Q3 		$215K Sell
35,050
-2,500
-7% -$16.9K 0.08% 187
2024
Q2 		$250K Buy
37,550
+22,850
+155% +$169K 0.09% 165
2024
Q1 		$150K Buy
+14,700
New +$150K 0.06% 205

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wealth Effects's ALT Position: Q1 2026 in Review

Wealth Effects increased its Altimmune (ALT) stake by 18% in Q1 2026, buying an estimated $85.8K and bringing the position to 131,950 shares worth $406K. The position accounts for 0.14% of the portfolio, ranked #130.

Wealth Effects first reported a position in ALT in Q1 2024 and has held it in 9 quarters since. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Wealth Effects held 131,950 shares of Altimmune worth $406K as of Q1 2026.
  • Wealth Effects bought 20,200 Altimmune shares in Q1 2026, an estimated $85.8K.
  • Altimmune made up 0.14% of Wealth Effects's portfolio in Q1 2026, its #130 holding.
  • Wealth Effects first reported a position in Altimmune in Q1 2024 and has held it in 9 quarters since.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.